Stem Cell Cure Hope for Diabetes
Scientists have used stem cells from human bone marrow to repair defective insulin-producing pancreatic cells responsible for diabetes in mice.
Seaweed Extract Makes Embryonic Stem Cells Safer for Injecting
Australian researchers say they have developed a treatment that provides a solution to an obstacle often cited in treating people with embryonic stem cells – the development of tumors.
Amniotic Stem Cells Offer Hope Against Congenital Heart Defects
If findings from a Swiss study prove true, in the future doctors will be able to use a simple procedure to extract stem cells from the mother’s amniotic fluid and use them to make a new heart valve, ready to place in the baby as soon as it is born.
Researchers Spur Growth of Adult Brain Stem Cells
Researchers have found a way to spur the growth of neural stem cells in the brains of adult mice with an eye toward harnessing the brain’s innate capacity for repair to help people with diseases such as Alzheimer’s.
Stem Cell Therapy Promises Hope for Muscular Dystrophy Victims
Italian scientists, by using new stem cell therapy on dogs with muscular dystrophy, have improved the dogs condition to such an extent that the dogs were able to walk and even jump again.
Adult Pig Stem Cells Show Promise in Repairing Animals’ Heart Attack Damage
Scientists have successfully grown large numbers of stem cells taken from adult pigs’ healthy heart tissue and used the cells to repair some of the tissue damage done to those organs by lab-induced heart attacks.
Advanced BioHealing Initiates Celaderm(TM) Clinical Trial
Advanced BioHealing, Inc. has announced that it has received conditional clearance from the United States Food and Drug Administration (FDA) to begin enrolling patients in a pilot trial of Celaderm(TM), the Company’s next generation bioengineered tissue product.
Initial Trials Indicate Reduced Intensity Stem Cell Transplant Safe For Scleroderma Patients
A phase I trial of non-myeloablative or reduced intensity hematopoietic stem cell transplantation (HSCT) in patients with systemic sclerosis (scleroderma) has proven safe and well tolerated.
Enrollment Completed Utilizing Cytori’s Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications
Cytori Therapeutics, Inc. was informed of the completion of enrollment of the 11 patient investigator-initiated RESTORE study in Japan using adipose-derived stem cells to treat the complications of surgery and radiation damage following partial mastectomy for the treatment of breast cancer.
Bioheart, Inc. Expands Clinical Trials of Adult Myogenic Stem Cell Treatment for Heart Attack and Advanced Heart Failure Patients
Bioheart, Inc. is expanding its United States and European clinical trials of its MyoCell(TM) adult myogenic (muscle) stem cell composition and MyoCath(R) needle-injection catheter product candidates.
Pervasis Therapeutics Announces Successful Initial Safety Results of Phase I Trials of Vascugel(TM) Cell-Based Gel to Repair Arteries
The trials were designed to study the safety of Vascugel(TM) in maintaining vascular patency in patients with arteriovenous access fistulas (AVF) and arteriovenous access grafts (AVG) for dialysis treatment of end-stage renal disease (ESRD).
Dendreon Completes Submission of Biologics License Application to FDA for PROVENGE in Hormone Refractory Prostate Cancer
Dendreon Corporation has announced the final portion of the Biologics License Application (BLA) for PROVENGE(R) (sipuleucel-T) has been electronically submitted to the U.S. Food and Drug Administration (FDA), which completes its rolling submission that began in August 2006.
King’s Scientists Submit Stem Cell Research Licence Application
Scientists from King’s submitted a licence application on November 6, 2006 to the Human Fertilisation and Embryology Authority (HFEA) to allow them to fuse human cells with animal eggs.
ABSTRACT, REVIEWS & SPECIAL REPORTS
Isolation of an Adult Blood-derived Progenitor Cell Population Capable of Differentiation into Angiogenic, Myocardial and Neural lineages
The simple and rapid method of synergetic cell population (a novel human cell population derived from the peripheral blood) and the resulting considerable quantities of lineage-specific precursor cells makes it a potential source of autologous treatment for a variety of diseases.